GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (STU:36M) » Definitions » EV-to-EBITDA

Shockwave Medical (STU:36M) EV-to-EBITDA : 59.05 (As of May. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shockwave Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shockwave Medical's enterprise value is €11,157.3 Mil. Shockwave Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €188.9 Mil. Therefore, Shockwave Medical's EV-to-EBITDA for today is 59.05.

The historical rank and industry rank for Shockwave Medical's EV-to-EBITDA or its related term are showing as below:

STU:36M' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1601.08   Med: -18.98   Max: 233.42
Current: 59.32

During the past 7 years, the highest EV-to-EBITDA of Shockwave Medical was 233.42. The lowest was -1601.08. And the median was -18.98.

STU:36M's EV-to-EBITDA is ranked worse than
90.76% of 487 companies
in the Medical Devices & Instruments industry
Industry Median: 16.36 vs STU:36M: 59.32

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Shockwave Medical's stock price is €303.00. Shockwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €3.952. Therefore, Shockwave Medical's PE Ratio for today is 76.67.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shockwave Medical EV-to-EBITDA Historical Data

The historical data trend for Shockwave Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical EV-to-EBITDA Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -25.27 -54.68 -1,482.46 56.49 35.65

Shockwave Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.50 62.96 40.58 35.65 58.49

Competitive Comparison of Shockwave Medical's EV-to-EBITDA

For the Medical Devices subindustry, Shockwave Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shockwave Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shockwave Medical's EV-to-EBITDA falls into.



Shockwave Medical EV-to-EBITDA Calculation

Shockwave Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=11157.269/188.938
=59.05

Shockwave Medical's current Enterprise Value is €11,157.3 Mil.
Shockwave Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €188.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shockwave Medical  (STU:36M) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shockwave Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=303.00/3.952
=76.67

Shockwave Medical's share price for today is €303.00.
Shockwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.952.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shockwave Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (STU:36M) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Shockwave Medical (STU:36M) Headlines

No Headlines